Lestaurtinib Uses, Dosage, Side Effects and more
| Trade Name | Lestaurtinib |
| Generic | Lestaurtinib |
| Lestaurtinib Other Names | Lestaurtinib |
| Type | |
| Formula | C26H21N3O4 |
| Weight | Average: 439.471 Monoisotopic: 439.153206168 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in pancreatic cancer, prostate cancer, and leukemia (myeloid).
How Lestaurtinib works
Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3.
